Cardinal/Bergen Argue That FTC Needs To Consider Entire Drug Market
Executive Summary
Drug wholesalers control only about half of the U.S. pharmaceutical market, Cardinal Health and Bergen Brunswig will argue in response to the Federal Trade Commission's legal challenge of the merger.